- Home
- CORT vs UMBF Comparison
CORT vs UMBF Comparison
Compare CORT & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- UMBF
- Stock Information
- Founded
- CORT 1998
- UMBF 1913
- Country
- CORT United States
- UMBF United States
- Employees
- CORT N/A
- UMBF N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- UMBF Major Banks
- Sector
- CORT Health Care
- UMBF Finance
- Exchange
- CORT Nasdaq
- UMBF Nasdaq
- Market Cap
- CORT 8.8B
- UMBF 9.1B
- IPO Year
- CORT N/A
- UMBF N/A
- Fundamental
- Price
- CORT $76.81
- UMBF $116.25
- Analyst Decision
- CORT Strong Buy
- UMBF Buy
- Analyst Count
- CORT 4
- UMBF 11
- Target Price
- CORT $139.00
- UMBF $137.00
- AVG Volume (30 Days)
- CORT 1.0M
- UMBF 434.9K
- Earning Date
- CORT 10-29-2025
- UMBF 10-28-2025
- Dividend Yield
- CORT N/A
- UMBF 1.38%
- EPS Growth
- CORT N/A
- UMBF 12.71
- EPS
- CORT 1.11
- UMBF 8.74
- Revenue
- CORT $716,080,000.00
- UMBF $1,949,350,000.00
- Revenue This Year
- CORT $30.77
- UMBF $67.93
- Revenue Next Year
- CORT $37.75
- UMBF $7.86
- P/E Ratio
- CORT $70.90
- UMBF $13.31
- Revenue Growth
- CORT 25.71
- UMBF 31.18
- 52 Week Low
- CORT $42.01
- UMBF $82.00
- 52 Week High
- CORT $117.33
- UMBF $129.94
- Technical
- Relative Strength Index (RSI)
- CORT 45.45
- UMBF 44.95
- Support Level
- CORT $69.43
- UMBF $113.71
- Resistance Level
- CORT $91.00
- UMBF $119.35
- Average True Range (ATR)
- CORT 4.07
- UMBF 2.84
- MACD
- CORT -1.83
- UMBF -0.47
- Stochastic Oscillator
- CORT 34.21
- UMBF 31.05
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.